About Abzena

Abzena provides integrated contract research, development, and manufacturing for complex biologics and bioconjugates, including antibody drug conjugates. With facilities across the United States and United Kingdom, the company delivers end to end support from discovery through commercial manufacturing. Over 20 years of expertise and proprietary technologies enable Abzena to tackle challenging programs other providers often avoid. Pharmaceutical and biotech companies partner with Abzena to accelerate timelines, reduce risk, and bring treatments to patients faster. Interconnected teams work across discovery, analytics, and GMP manufacturing, ensuring seamless transitions and proactive problem solving throughout the development lifecycle.